2020
The B cell immunobiology that underlies CNS autoantibody-mediated diseases
Sun B, Ramberger M, O’Connor K, Bashford-Rogers RJM, Irani SR. The B cell immunobiology that underlies CNS autoantibody-mediated diseases. Nature Reviews Neurology 2020, 16: 481-492. PMID: 32724223, PMCID: PMC9364389, DOI: 10.1038/s41582-020-0381-z.Peer-Reviewed Original ResearchConceptsAutoantigen-specific B cellsB cellsPathogenic autoantibodiesB cell tolerance checkpointsAutoantibody-mediated diseasesB cell immunobiologyLong-term morbidityHigher serum levelsCirculation of patientsSource of autoantibodiesSite of pathologyB-cell lineageClinical relapseAvailable medicationsSerum levelsIntrathecal synthesisCNS diseaseTolerance checkpointsPlasma cellsTherapeutic effectCerebrospinal fluidGerminal centersAutoantibodiesDiseasePatients
2015
Chapter 40 Myoclonus Classification, Clinical Features, and Genetics
Patel A, Frucht S. Chapter 40 Myoclonus Classification, Clinical Features, and Genetics. 2015, 655-670. DOI: 10.1016/b978-0-12-405195-9.00040-8.Peer-Reviewed Original ResearchHyperkinetic movement disordersClassification of myoclonusSite of pathologyMyoclonus physiologyClinical featuresNeurologic disordersEtiologic classificationMovement disordersMyoclonusParticular therapyNervous systemPeripheral centersParticular disorderDisordersGenetic heterogeneityTherapyEtiologyPhysiologyCliniciansDiagnosisPathologyPhysiologic
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply